Triple-negative breast cancer: epidemiological considerations and recommendations

Boyle, 2006, The globalisation of cancer, Lancet, 368, 629, 10.1016/S0140-6736(06)69225-8 Boyle, 2008 Autier, 2010, Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database, Br Med J, 341, c3620, 10.1136/bmj.c3620 Jemal, 2007, Recent trends in breast cancer incidence rates by age and tumour characteristics among United States women, Breast Cancer Res, 9, R28, 10.1186/bcr1672 Beatson, 1896, On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases, Lancet, 148, b104, 10.1016/S0140-6736(01)72307-0 Nielsen, 2004, Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma, Clin Cancer Res, 10, 5367, 10.1158/1078-0432.CCR-04-0220 Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093 Sotiriou, 2009, Gene-expression signatures in breast cancer, N Engl J Med, 360, 790, 10.1056/NEJMra0801289 Bertucci, 2008, How basal are triple-negative breast cancers?, Int J Cancer, 123, 236, 10.1002/ijc.23518 Bidard, 2007, Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 ‘triple-negative’ breast cancers, Ann Oncol, 18, 1285, 10.1093/annonc/mdm360 Vona-Davis, 2008, Triple-negative breast cancer and obesity in a rural Appalachian population, Cancer Epidemiol Biomarkers Prev, 17, 3319, 10.1158/1055-9965.EPI-08-0544 Carey, 2006, Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study, JAMA, 295, 2492, 10.1001/jama.295.21.2492 Rakha, 2006, Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance, Eur J Cancer, 42, 3149, 10.1016/j.ejca.2006.08.015 Sorlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci U S A, 98, 10869, 10.1073/pnas.191367098 Brown, 2008, The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999–2004, Cancer, 112, 737, 10.1002/cncr.23243 Carey, 2007, The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes, Clin Cancer Res, 13, 2329, 10.1158/1078-0432.CCR-06-1109 Cheang, 2008, Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype, Clin Cancer Res, 14, 1368, 10.1158/1078-0432.CCR-07-1658 Lund, 2009, Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA, Breast Cancer Res Treat, 113, 357, 10.1007/s10549-008-9926-3 Perou, 2000, Molecular portraits of human breast tumours, Nature, 406, 747, 10.1038/35021093 Sorlie, 2003, Repeated observation of breast tumor subtypes in independent gene expression data sets, Proc Natl Acad Sci U S A, 100, 8418, 10.1073/pnas.0932692100 Sørlie, 2006, Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer, Mol Cancer Ther, 5, 2914, 10.1158/1535-7163.MCT-06-0126 Sørlie, 2001, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc Natl Acad Sci U S A, 98, 10869, 10.1073/pnas.191367098 Sørlie, 2006, Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms, BMC Genomics, 7, 127, 10.1186/1471-2164-7-127 Foulkes, 2010, Triple-negative breast cancer, N Engl J Med, 363, 1938, 10.1056/NEJMra1001389 Anders, 2009, Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer, Clin Breast Cancer, 9, S73, 10.3816/CBC.2009.s.008 Rakha, 2009, Triple-negative/basal-like breast cancer: a review, Pathology, 41, 40, 10.1080/00313020802563510 Bauer, 2007, Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study hrom the California Cancer Registry, Cancer, 109, 1721, 10.1002/cncr.22618 Stead, 2009, Triple-negative breast cancers are increased in black women regardless of age or body mass index, Breast Cancer Res, 11, R18, 10.1186/bcr2242 Kwan, 2009, Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors, Breast Cancer Res, 11, R31, 10.1186/bcr2261 Kurian, 2010, Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups, Breast Cancer Res, 12, R99, 10.1186/bcr2780 Amirikia, 2011, Higher population-based incidence rates of triple-negative breast cancer among young African-American women: implications for breast cancer screening recommendations, Cancer, 117, 2747, 10.1002/cncr.25862 Huo, 2009, Population differences in breast cancer: survey in indigenous african women reveals over-representation of triple-negative breast cancer, J Clin Oncol, 27, 4515, 10.1200/JCO.2008.19.6873 Stark, 2010, African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study, Cancer, 116, 4926, 10.1002/cncr.25276 Lakhani, 2002, The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2, J Clin Oncol, 20, 2310, 10.1200/JCO.2002.09.023 Vona-Davis, 2008, Triple-negative breast cancer and obesity in a rural appalachian population, Cancer Epidemiol Biomarkers Prev, 17, 3319, 10.1158/1055-9965.EPI-08-0544 Trivers, 2009, The epidemiology of triple-negative breast cancer, including race, Cancer Causes Control, 20, 1071, 10.1007/s10552-009-9331-1 Shinde, 2010, Higher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer, Cancer, 116, 4933, 10.1002/cncr.25443 Dolle, 2009, Risk factors for triple-negative breast cancer in women under age 45, Cancer Epidemiol Biomarkers Prev, 18, 1157, 10.1158/1055-9965.EPI-08-1005 Phipps, 2011, Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer, J Natl Cancer Inst, 103, 470, 10.1093/jnci/djr030 Kabat, 2011, Smoking and alcohol consumption in relation to risk of triple-negative breast cancer in a cohort of postmenopausal women, Cancer Causes Control, 22, 775, 10.1007/s10552-011-9750-7 Akarolo-Anthony, 2010, Emerging breast cancer epidemic: evidence from Africa, Breast Cancer Res, 12, S8, 10.1186/bcr2737 Bedard, 2010, Use of meta-analysis of gene expression profiling studies to identify biologically relevant pathways associated with aggressive breast cancer (BC) in young women, J Clin Oncol, 28, 15s, 10.1200/jco.2010.28.15_suppl.520 Lim, 2009, Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers, Nat Med, 15, 907, 10.1038/nm.2000 Prat, 2009, Mammary development meets cancer genomics, Nat Med, 15, 842, 10.1038/nm0809-842